Neurokappa Therapeutics
Neurokappa Therapeutics
Categories
Biotech Pharmaceutical Pharmaceutical
About
Neurokappa Therapeutics is a start-up biopharmaceutical company focused on the development of Salvinorin A for the prevention and treatment of cerebral vasospasm following subarachnoid hemorrhage. Salvinorin A is the active drug substance isolated from the leaves of the Salvia divinorum plant and has been used recreationally for its short-lived psychotropic effects.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – biotechnology and diagnostic companies, medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.